TCM Biotech International (ROCO:4169) Long-Term Debt : NT$59.7 Mil (As of Dec. 2023)

View and export this data going back to 2012. Start your Free Trial

What is TCM Biotech International Long-Term Debt?

TCM Biotech International's Long-Term Debt for the quarter that ended in Dec. 2023 was NT$59.7 Mil.

TCM Biotech International's quarterly Long-Term Debt declined from Dec. 2022 (NT$93.6 Mil) to Jun. 2023 (NT$89.5 Mil) and declined from Jun. 2023 (NT$89.5 Mil) to Dec. 2023 (NT$59.7 Mil).

TCM Biotech International's annual Long-Term Debt declined from Dec. 2021 (NT$104.5 Mil) to Dec. 2022 (NT$93.6 Mil) and declined from Dec. 2022 (NT$93.6 Mil) to Dec. 2023 (NT$59.7 Mil).

TCM Biotech International Long-Term Debt Historical Data

The historical data trend for TCM Biotech International's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TCM Biotech International Long-Term Debt Chart

TCM Biotech International Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Long-Term Debt

Get a 7-Day Free Trial

123.57

113.89

104.51

93.58

59.69

TCM Biotech International Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Long-Term Debt	Get a 7-Day Free Trial															104.51	99.80	93.58	89.54	59.69

TCM Biotech International (ROCO:4169) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

TCM Biotech International Long-Term Debt Related Terms

Thank you for viewing the detailed overview of TCM Biotech International's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

TCM Biotech International (ROCO:4169) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » TCM Biotech International Corp (ROCO:4169) » Definitions » Long-Term Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 97, Sec. 1, Xintai 5th Road, Xizhi District, Neihu District, Taipei, TWN, 221

Website

http://www.tcmbio.com

TCM Biotech International Corp is a Taiwan based biotechnology company. It is engaged in the research and development of therapeutics for the prevention and treatment of liver diseases. Its products includes Anti-adhesion System, Anti-neoplastic agents, Osteoporosis Treatment Preparation, Iron Preparations, Osteoarthritis (OA) Treatment Products, Urinary System Treatment Products and others. The company has a business presence in Taiwan and other international countries such as the United States, Japan, Singapore, Malaysia, Vietnam, the Philippines and China. The entity derives key revenue from the sales of multiple medical products which includes medicine, medical device, functional food and others.

TCM Biotech International (ROCO:4169) Headlines

No Headlines